申请人:NOVARTIS AG
公开号:US10077240B2
公开(公告)日:2018-09-18
The present invention relates to compounds of Formula I,
a stereoisomer, enantiomer, a pharmaceutically acceptable salt or an amino acid conjugate thereof; wherein variables are as defined herein; and their pharmaceutical compositions, which are useful as modulators of the activity of Farnesoid X receptors (FXR).
本发明涉及式 I 的化合物、
其立体异构体、对映体、药学上可接受的盐或氨基酸共轭物;其中变量如本文所定义;以及它们的药物组合物,可用作法尼类固醇 X 受体(FXR)活性的调节剂。